Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:06 August,2020

‘Most patients who recovered in Wuhan suffer lung damage’

Ninety per cent of a sample group of coronavirus-recovered patients from a prominent hospital in China’s Wuhan city where the pandemic broke out have reported lung damage and five per cent of them are again in quarantine after testing positive for the virus, according to a media report on Wednesday. A team at the Zhongnan Hospital of Wuhan University led by Peng Zhiyong, director of the hospital’s ICU, has been conducting follow-up visits with 100 recovered patients since April. The first phase of this one-year programme finished in July. The average age of the patients in the study is 59. According to the first phase results, 90% of the patients’ lungs are still in a damaged state, which means their lungs ventilation and gas exchange functions have not recovered to the level of healthy people, state-run Global Times reported. ....read more


Brain Health and COVID -19

Join us today as we discuss the neurological manifestations of COVID-19 on Medtalks with Dr K K Aggarwal COVID edition at 7:00 pm.
Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php


World COVID Meter 5th August: India Number 3, 213 Countries Affected

Cases:1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1 ,Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity ,Coronavirus Cases: 18,709,161,Deaths: 704,438,Recovered: 11,926,224,ACTIVE CASES: 6,078,499Currently Infected Patients ,6,013,163 (99%) in Mild Condition....read more


Gargling is a potential preventive strategy to reduce COVID-19 transmission

Coronavirus disease or COVID-19 is caused by a novel Coronavirus, which has been officially named as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). The disease is now six months old, but continues to be a global public health crisis and is showing no signs of stopping. The virus has rampaged across the world infecting more than16 million people; nearly 7 lakh people have died due to the infection. ,Since COVID-19 is a new disease caused by a new pathogen, there are no proven treatment options or vaccine. Treatment is mainly supportive although potential therapies are being explored. Existing drugs like hydroxychloroquine, azithromycin are being repurposed for treatment. ....read more


Vedic Fasting

Fasting and starvation are two different terms commonly confused with each other. ,Starvation means not eating or drinking altogether, while fasting means control and restrain of five sensory and five motor senses. ,During fasting, one may continue eating or drinking but under discipline. Vedic fasting or spiritual fasting is mentioned in Karam Kanda in Yajurveda....read more


Video of The day

Hot water or luke warm water for COVID 19


Medbytes

       


Healthcare News Monitor
Exclusive R&D policy for pharma sector soon; these three issues may be resolved too
Finalcial Express

The center is soon to come up with an exclusive Research and Development policy for the pharmaceutical sector soon as it looks to take India’s pharma sector on par with countries like US and Europe. “We are working (on the R&D policy) … so our department has taken the initiative through industry academia interaction for framing this policy and we are likely to finalise it shortly,” PD Vaghela, Secretary of Department of Pharmaceuticals, said at a virtual event organised on the 77th Foundation day of CSIR-Indian Institute of Chemical Technology on Wednesday, PTI reported. He also said that this will be a major push for scientists to come up with new innovations.

Indian pharma industry expected to be stable this year, says credit rating agency
India Today

The Indian pharmaceutical industry is expected to register a growth of 14.2 percent in the second quarter of the current financial year contrary to 4.8 percent in the first quarter, a study by Information and Credit Rating Agency (ICRA) has found. The growth could be attributed to the outbreak of many diseases in many parts aiding the growth of the anti-infective segment. ,Gaurav Jain, Vice President and Co-head of ICRA, said the global demand scenario is largely expected to remain stable for Indian pharmaceutical industry owing to inelastic nature of prescription drugs though some impact on volume growth will be felt owing to lockdown (lesser OPDs / Elective surgeries) and lower economic growth. “The impact of lower demand will be felt more in less developed countries which are additionally negatively impacted owing to low crude oil prices,” he said.

Covid learning: Digi-health is the future, only this can help India deliver what it needs to
Finalcial Express

Even before the pandemic exposed the faultlines of India’s health infrastructure—even in big cities like Delhi and Mumbai—it was always clear it was bursting at the seams. With just 0.6 doctors per 1,000 population and 2.2 nurses, as compared to the WHO’s norm of 1 and 3, respectively, India simply cannot cope with the demands made by its citizens even in non-pandemic situations. Indeed, unless the level of Covid-19 infections are milder than those seen in some countries, India will be hard-pressed to deal with the situation considering the infection is rapidly spreading to semi-urban and rural areas.

Tripura doctors stage protest over suspension of colleague posted at Covid Care centre
hindustantimes

A doctor posted at a Covid-19 Care Centre of Govind Ballabh Panth (GBP), the only dedicated Covid-19 hospital in Tripura, was suspended on Tuesday. The move invited protests from the doctors and medical staff. Dr Uttam Bhattacharjee, an assistant professor of Ophthalmology department of the Agartala Government Medical College (AGMC), was suspended under sub-rule (I) of Rule 10 of the Central Civil Service (Classification, Control and Appeal) Rules, 1965 and a disciplinary action is contemplated against him, according to an order served by joint secretary Debasish Das. Dr Bhattacharjee was asked not to leave the capital city without permission of the concerned authority.